Contact
Please use this form to send email to PR contact of this press release:
Frontotemporal Dementia Pipeline Therapeutics, Clinical Trials Assessment, Emerging Drugs and Companies | DelveInsight
TO:
Yash Bhardwaj
DelveInsight
+91 96502 13330